Pharmaceutical Technology: Wu Xihan reduces his stake in the company by 0.37%.

Pharmaceutical Technology Corporation announced that shareholder Wu Xihan has completed the reduction plan, reducing a total of 743,800 shares, accounting for 0.37% of the total share capital of the company excluding the repurchased shares. The reduction period was from May 13, 2025 to May 20, 2025, with an average reduction price of 32.84 yuan per share. This reduction plan complies with relevant laws, regulations, and normative documents and will not result in a change in the company's controlling ownership.